NMD4C and MDC are pleased to invite you to a webinar on FSHD clinical updates. NMD4C and MDC are providing organizational and technical support. This is a an independent clinical/academic webinar with no industry sponsorship or influence.

Register at: https://bit.ly/FSHClinicalUpdates

Chair and Speaker

• Dr Lawrence Korngut | Neuromuscular Neurologist, Associate Professor, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary: Avidity Biosciences FORTITUDE Trial Interim Results and CNDR FSHD

Speakers

• Dr Patrick Horn | Chief Medical Officer of Fulcrum Therapeutics: Results of a phase 3 study of losmapimod in the treatment of FSHD
• Dr. Eva Chin | Executive Director of SOLVE FSHD: Catalysing Innovation in FSHD Therapeutics

Learning Objectives

• Innovative new therapies on the horizon for FSHD
• The role of patient foundations and patient-funded R&D for accelerating novel therapies
• Understand the outcome to the REACH study of losmapimod in FSHD
• Introducing the CNDR FSHD Module

The NMD Rounds & Educational Webinars is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

If you have any questions, please email <>